Evidence map›Paper›PMID 34886179›Full record

ArticleInternational journal of environmental research and public health2021

The Willingness to Pay for a Hypothetical Vaccine for the Coronavirus Disease 2019 (COVID-19).

Yoshiro Tsutsui, Shosh Shahrabani, Eiji Yamamura, Ryohei Hayashi, Youki Kohsaka, Fumio Ohtake

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Yoshiro TsutsuiFaculty of Social Relations, Kyoto Bunkyo University, Uji 611-0041, Japan.
Shosh ShahrabaniHead of Research Authority, The Max Stern Yezreel Valley College, Emek Yezreel P.O. 1930600, Israel.
Eiji YamamuraDepartment of Economics, Seinan Gakuin University, Fukuoka 814-8511, Japan.ORCID 0000-0002-5903-3582
Ryohei HayashiSchool of Economics & Management, Kochi University of Technology, Kochi 780-8515, Japan.ORCID 0000-0002-2228-0897
Youki KohsakaDepartment of Management Information, Kyoto College of Economics, Kyoto 610-1195, Japan.ORCID 0000-0002-3633-2272
Fumio OhtakeCenter for Infectious Disease Education and Research, Osaka University, Osaka 560-0043, Japan.
Kochi University of Technology · JPKyoto Bunkyo University · JPKyoto College of Economics · JPSeinan Gakuin University · JPThe Max Stern Yezreel Valley College · ILThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates how people in Japan perceived the severity of and probability of infection from coronavirus disease 2019 (COVID-19), and how their willingness to purchase a hypothetical vaccine depends on these perceptions and their risk attitudes. We conducted a large-scale panel survey three times between 13 March to 13 April 2020 in Japan. By analyzing the data, we found that the perception of COVID-19 became more serious. The estimation of the fixed effect model reveals that a person becomes more willing to pay for a vaccine as the person evaluates COVID-19 as a more severe disease, considers a higher probability of infection, and becomes more risk averse. Since the sensitivity of willingness to pay for the vaccine on risk aversion increased during the period, the change in risk attitude contributed to an increase in willingness through the sensitivity channel, while it decreased through the magnitude channel.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 VaccinesVaccinesCOVID-19health belief modelrisk attitudevaccine

Identifiers

PMID34886179
PMCPMC8657379
OpenAlexW3214864609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.